Announce Date | 02/03/2025 |
EPS Normalized Actual | $1.31 (Beat by $0.21) |
EPS GAAP Actual | $1.31 (Beat by $0.21) |
Revenue Actual | $4.01415B |
Revenue Surprise | Beat by $4014.15M |
Announce Date | 03/30/2025 (Pre-Market) |
EPS Normalized Estimate | $1.19377 |
EPS GAAP Estimate | $1.19377 |
Revenue Estimate | $1.916461333B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Sep 2027 | 7.68 | 12.3 | 7.60446 | 7.7154 | 1 |
Sep 2026 | 6.48 | 14.57 | 6.48 | 6.48 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 1.26 | 1.26 | 4.01415B | 2.85% | 4014.15M |
FQ3 2024 (Sep 2024) | 1.29 | 1.29 | 4.11049B | 6.52% | 4110.49M |
FQ2 2024 (Jun 2024) | 0.99 | 0.99 | 4.15125B | 11.75% | 4151.25M |
FQ1 2024 (Mar 2024) | 0.92 | 0.92 | 3.94383B | 11.5% | 3943.83M |
FQ4 2023 (Dec 2023) | 0.69 | 0.69 | 3.89992B | 13.27% | 3899.92M |
FQ3 2023 (Sep 2023) | 0.18 | 0.18 | 3.84238B | 10.83% | 3842.38M |
FQ2 2023 (Jun 2023) | -0.97 | -0.97 | 3.66355B | 11.52% | 3663.55M |
FQ1 2023 (Mar 2023) | 0.91 | 0.91 | 3.49017B | 100% | 3490.17M |
FQ4 Announce Date
03/30/2025 (Pre-Market)
Consensus EPS Estimates
1.19377
Consensus Revenue Estimates
1.916461333B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ2 2027 (Jun 2027) | 1.60597 | -- | 1.59711 | 1.61531 | 2 |
FQ1 2027 (Mar 2027) | 1.48924 | -- | 1.48102 | 1.4979 | 2 |
FQ4 2026 (Oct 2026) | 1.42692 | -- | 1.38783 | 1.45834 | 1 |
FQ3 2026 (Jul 2026) | 1.39298 | -- | 1.35482 | 1.42366 | 1 |
FQ2 2026 (Jun 2026) | 1.39122 | -- | 1.27223 | 1.44278 | 3 |
FQ1 2026 (Mar 2026) | 1.2975 | -- | 1.18653 | 1.34559 | 3 |
FQ4 2025 (Oct 2025) | 1.38661 | 9.13 | 1.36962 | 1.41301 | 0 |
FQ3 2025 (Jul 2025) | 1.32842 | 2.89 | 1.31214 | 1.35371 | 0 |
FQ2 2025 (Jun 2025) | 1.33092 | 25.62 | 1.29791 | 1.37644 | 2 |
FQ1 2025 (Mar 2025) | 1.19377 | 22.93 | 1.16416 | 1.2346 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ2 2027 (Jun 2027) | 4.72B | -- | 4.7B | 4.74B | 1 |
FQ1 2027 (Mar 2027) | 4.66B | -- | 4.64B | 4.68B | 1 |
FQ4 2026 (Oct 2026) | 3.34B | -- | 3.27B | 3.4B | 1 |
FQ3 2026 (Jul 2026) | 3.4B | -- | 3.33B | 3.45B | 1 |
FQ2 2026 (Jun 2026) | 3.64B | -- | 3.4B | 3.74B | 4 |
FQ1 2026 (Mar 2026) | 3.7B | -- | 3.45B | 3.8B | 4 |
FQ4 2025 (Oct 2025) | 1.98B | -102.39 | 1.96B | 2.01B | 0 |
FQ3 2025 (Jul 2025) | 1.97B | -108.84 | 1.95B | 2B | 0 |
FQ2 2025 (Jun 2025) | 1.97B | -110.59 | 1.93B | 2.02B | 0 |
FQ1 2025 (Mar 2025) | 1.92B | -105.79 | 1.88B | 1.97B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 1.26 | 1.26 | 100% | |
FQ3 2024 (Sep 2024) | 1.29 | 1.29 | 100% | |
FQ2 2024 (Jun 2024) | 0.99 | 0.99 | 100% | |
FQ1 2024 (Mar 2024) | 0.92 | 0.92 | 100% | |
FQ4 2023 (Dec 2023) | 0.69 | 0.69 | 100% | |
FQ3 2023 (Sep 2023) | 0.18 | 0.18 | 100% | |
FQ2 2023 (Jun 2023) | -0.97 | -0.97 | 100% | |
FQ1 2023 (Mar 2023) | 0.91 | 0.91 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $4.01B | $4014.15M | 100% |
FQ3 2024 (Sep 2024) | $0B | $4.11B | $4110.49M | 100% |
FQ2 2024 (Jun 2024) | $0B | $4.15B | $4151.25M | 100% |
FQ1 2024 (Mar 2024) | $0B | $3.94B | $3943.83M | 100% |
FQ4 2023 (Dec 2023) | $0B | $3.9B | $3899.92M | 100% |
FQ3 2023 (Sep 2023) | $0B | $3.84B | $3842.38M | 100% |
FQ2 2023 (Jun 2023) | $0B | $3.66B | $3663.55M | 100% |
FQ1 2023 (Mar 2023) | $0B | $3.49B | $3490.17M | 100% |